FDDS

Floating drug delivery system is a recent advancement in pharmaceutical technology which has also several advantages over the conventional drug delivery systems. Those advantages of floating system can be used in the treatment of world’s most affective diseases like cardiovascular diseases. Cardiovascular diseases are group of diseases which are many of the time fetal for the patients due to problems associated with the oral conventional tablets. These problems can be overcome by this delivery system. With an increasing understanding of polymer behavior and the role of the biological factors, it is suggested that future research work on the way of floating drug delivery system should be aimed to control accurately the drug input rate into the gastrointestinal tract for the optimization of the pharmacokinetic and toxicological profiles of cardiovascular agents. This review gives an overview of cardiovascular disease, floating drug delivery system & role of floating drug delivery system in treatment of heart patient.

The real challenge in the development of an oral controlled-release drug delivery system is not just to sustain the drug release but also to prolong the presence of the dosage form within the gastrointestinal tract (GIT) until all the drug is completely released at the desired period of time. Floating drug delivery systems (FDDS) have ability to prolong the gastric residence time after oral administration at proper site and release of drug controlled also useful to achieve desired peak plasma concentration and increase bioavailability. This review specify characteristics as well as evaluation of floating microspheres